Despite clear WHO guidance and proven interventions, advanced HIV disease (AHD) remains a major driver of HIV-related mortality. As the global HIV response pivots toward integration, sustainability and constrained funding environments, there is a risk that AHD - often complex, resource-intensive and affecting the most vulnerable - becomes deprioritized.
As countries navigate funding transitions and service integration, attention may shift away from those most at risk, including in inpatient settings where mortality remains highest.
This satellite confronts the gap between knowledge and delivery. Through clinical evidence, national programme experience, costing data and funder perspectives, speakers will examine why lifesaving diagnostics and treatments still fail to reach those most at risk, particularly in inpatient settings.
The session aims to provoke honest discussion about difficult trade-offs and identify urgent actions needed to ensure AHD prevention and treatment remain central to the HIV agenda and not an afterthought. The session will aim to identify a small set of priority actions for national programmes, implementers and funders to safeguard AHD services during the next phase of the HIV response.
